SEC
SlamSEC
SearchBrowseEarnings

Fortress Biotech, Inc.

Nasdaq:FBIONasdaq:FBIOP
Pharmaceutical Preparations·BAY HARBOR ISLANDS, FL
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(865 total)

TypeDateAccessionPeriodSize
8-K
Feb 23, 2026
0001104659-26-0183718-K
Feb 22, 2026
250.5 KB
8-K
Jan 13, 2026
0001104659-26-0031218-K
Jan 13, 2026
261.0 KB
SCHEDULE 13D/A
Jan 6, 2026
0001104659-26-001305
—
14.1 KB
4
Jan 6, 2026
0001429260-26-000004
Jan 2, 2026
5.3 KB
SCHEDULE 13D/A
Jan 5, 2026
0001104659-26-000690
—
14.5 KB
4
Jan 5, 2026
0001647971-26-000002
Jan 1, 2026
5.5 KB
4
Jan 5, 2026
0001529687-26-000002
Jan 1, 2026
5.5 KB
4
Jan 5, 2026
0001772558-26-000002
Jan 1, 2026
4.9 KB
4
Jan 5, 2026
0001429260-26-000002
Jan 2, 2026
5.2 KB
4
Jan 5, 2026
0001294517-26-000002
Jan 1, 2026
5.5 KB
4
Jan 5, 2026
0001172659-26-000002
Jan 1, 2026
5.5 KB
424B3
Dec 18, 2025
0001104659-25-122537424B3
—
172.4 KB
EFFECT
Dec 17, 2025
9999999995-25-003815
—
1.8 KB
S-1
Dec 16, 2025
0001104659-25-121266FORM S-1
—
1.2 MB
8-K
Dec 15, 2025
0001104659-25-1211878-K
Dec 12, 2025
185.7 KB
8-K
Dec 15, 2025
0001104659-25-1208938-K
Dec 15, 2025
252.4 KB
8-K
Nov 17, 2025
0001104659-25-112945FORM 8-K
Nov 14, 2025
231.7 KB
10-Q
Nov 14, 2025
0001104659-25-11198910-Q
Sep 30, 2025
17.4 MB
8-K
Nov 14, 2025
0001104659-25-1119798-K
Nov 14, 2025
558.3 KB
4
Oct 2, 2025
0001930732-25-000004
Oct 1, 2025
5.0 KB
SCHEDULE 13D/A
Oct 1, 2025
0001104659-25-095631
—
14.5 KB
4
Oct 1, 2025
0001429260-25-000004
Sep 29, 2025
5.3 KB
8-K
Oct 1, 2025
0001104659-25-0953668-K
Oct 1, 2025
231.0 KB
10-Q
Aug 14, 2025
0001558370-25-01157010-Q
Jun 30, 2025
16.5 MB
8-K
Aug 14, 2025
0001558370-25-0115618-K
Aug 14, 2025
551.1 KB
25 filings shown

, commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A.